InvestorsHub Logo
Followers 21
Posts 2233
Boards Moderated 0
Alias Born 02/22/2005

Re: jakedogman1 post# 17126

Thursday, 09/13/2007 5:41:19 PM

Thursday, September 13, 2007 5:41:19 PM

Post# of 346182
jake,

I hope you're joking.

erbitux is....

well....


It's pretty darn toxic stuff, for a marginal benefit, in a small subclass of tumors.


No comparison to Bavituximab, if bavi simply keeps performing as it already has.

Bavi's target is on all tumor blood supplies, all enveloped viruses, parasites, etc...

and bavi's target also just happens to be THE MOLECULE that is the "fork in the road" in our immune response that 'turns off' a specific tough fight against all the tumors/viruses/parasites....



"multiple mechanisms"


j



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News